FM Continuous Monitoring of Intraocular Pressure, an Engineering Perspective by Rendon‐Nava, Adrian E. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 5
FM Continuous Monitoring of Intraocular Pressure, an
Engineering Perspective
Adrian E. Rendon‐Nava,
Alejandro Díaz‐Méndez and Luis Nino‐de‐Rivera
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/65294
Provisional chapter
FM Continuous Monitoring of Intraocular Pressure, an
Engineering Perspective
Adrian E. Rendon‐Nava,
Alejandro Díaz‐Méndez and Luis Nino‐de‐Rivera
Additional information is available at the end of the chapter
Abstract
This chapter discusses the problem of continuously monitoring intraocular pressure
(IOP) from an engineering perspective. It is aimed to all public in general although we
think that medical staff and engineers may benefit the most from it. Although equations
are included for engineers to get a glimpse of how the system works, this chapter does
not go into great detail in mathematics and physics to make it understandable to medical
staff. It provides though references for engineers who wish to get a better understanding
of key subjects tackled in this chapter. The chapter is organized as follows: Section 1
introduces intraocular pressure (IOP) and need for its continuous monitoring. Section
2 describes the most recent efforts to develop a continuous IOP monitoring system.
Section 3  shows what  medical  and engineering considerations must  be taken into
account to effectively measure IOP. Section 4 deals with health issues due to tissue
warming and how to prevent them. Section 5 explains how an implant can be fabricated
using either passive electronic components or active ones. Finally, Section 6 explains
how the pressure sensor and the electronic circuits can be integrated.
Keywords: biomedical implants, IOP monitoring, magnetic coupling, wireless cou‐
pling, wireless power transmission
1. Introduction
Before we can begin to talk about intraocular pressure (IOP) continuous monitoring, let us
have a look at some key facts according to the World Health Organization (WHO) [1]:
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• There are 285 million people estimated to be visually impaired worldwide, of which 246
million have low vision.
• About 90% of the visually impaired people globally live in low‐income environments.
• Eighty per cent of all visual impairment can be prevented or cured.
Among the three major causes globally that cause visual impairment is glaucoma. Glaucoma
can be understood as a group of ocular diseases mainly associated with a rise in intraocular
pressure. All these groups of diseases have in common the progressive injury to the optic
nerve [2]. If glaucoma is left untreated, it can cause total blindness.
The problem with diseases such as glaucoma is that they present no symptoms, so trying to
diagnose it without previously measuring the IOP becomes a real challenge. Actual methods
for IOP measurement involve the use of medical equipment called tonometers. Tonometers
measure IOP over the cornea but in some cases, where the hardness of the cornea is above
normal standards, important measurement errors can be produced which do not allow a
correct IOP estimation.
There are nowadays other indirect methods that have been under research in the last years
such as multifocal electroretinography to know the effects of IOP rising [3]. Nevertheless, with
available tonometry and electroretinography techniques, it is not possible to take measure‐
ments during normal activities of the patient such as the sleep cycle, stage where IOP can be
increased in a significant manner. In order to take an IOP measurement with tonometry or
multifocal electroretinography methods, the measurement must be taken by qualified
personnel which implies that the patient has to be in the hospital facilities.
The development of sensors with the capacity of measuring IOP inside the eyeball is of
paramount importance in order to know with all precision not only intraocular pressure values
but also IOP variations in daily activities of the patients.
A new measurement instrument is needed that allows medical staff to study the aetiology of
diseases such as glaucoma, that is, to provide with a new tool which will enable to know if
there is a cause‐effect relationship between daily activities of patients and IOP variations in
real time.
Fortunately, we are at a point where technology has evolved in such a way that biomedical
implants wirelessly powered are now a reality.
2. State of the art
There have been many efforts in different parts of the world over time to build an IOP
monitoring system. In this section, we only present a few researches to give the reader a broad
idea of what has been done in terms of IOP monitoring systems but references [4–8] are
included in case the reader wants to know more about researches not mentioned in this chapter.
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Between the first researches carried out, there is the one done by Tufte et al. when in 1962 in
Honeywell, they developed piezoresistive sensors with silicon membranes [9].
In 2000, Mokwa, Schnakenberg and collaborators proposed the design and fabrication of an
implantable intraocular system for continuous IOP measurement through OPHTAL project
[10]. The system consisted of a pressure sensor connected to the integrated circuits altogether
in an artificial contact lens. Three prototypes were fabricated. The last one is shown in Figure 1.
Figure 1. Third pressure sensor prototype.
Humayun and collaborators proposed in 2008 a prototype sensor to measure IOP [11]. Two
sensor designs were fabricated, one with a variable capacitor and the other one with a variable
capacitor and a variable inductor (Figure 2).
The pressure sensor response showed a high sensitivity (>7000 ppm/mmHg) in both designs,
confirming a resolution of less than 1 mmHg for biomedical applications. The authors also
conducted a 6‐month study in animals to verify the implant bio‐stability in vivo and no surgical
or post‐operation complications were found.
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Figure 2. Sensor design variations (cross‐sectional view).
Figure 3. Sensor device.
In 2011, Melki and collaborators published a study with the purpose of determining the
biocompatibility of an IOP sensor in rabbits and comparing IOP measurements from the sensor
with other IOP sensor devices [12]. Figure 3 shows the photograph of the sensor encapsulated
in a silicon rubber.
The intraocular sensor was implanted in six New Zealand white rabbits. The upper part of the
sensor contains the Application‐Specific Integrated Circuit (ASIC). The external diameter of
the coil was of 11.3 mm, the inner diameter was of 7 mm and the thickness was of 0.9 mm.
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The animals were observed and examined in intervals of up to 25 months after surgery. From
the obtained results, it was found that the sensor had acceptable tolerance by the eye of the
rabbit since no evidence of significant inflammation or scar formation was observed in in vivo
tests. The measurements made with pneumotonometry, tonometry and with the sensor
resulted in standard deviations of 2.70, 3.35 and 0.81 mmHg, respectively.
3. Merging medicine and engineering
As seen in the previous section, all efforts to build a continuous IOP monitoring system
proposed a wireless power transmission method. This obeys to the fact that having a battery
inside the eye to power the biomedical implant can be both bulky and most importantly health
threatening to the patient due to the hazardous chemicals it contains.
If we are to develop a continuous IOP monitoring system, we need to approach the problem
with a multidisciplinary focus.
3.1. Medical considerations
The human eyeball measures approximately 2.5 cm in diameter so there is a restriction in terms
of the maximum area that the implant can have to be successfully implanted in the patient.
Among medical factors that come into play for implanting a continuous IOP monitoring
system are the following:
• The location of the implant must not interfere with the vision and movement of the eye.
• Surgery should be as less invasive as possible.
• Implant design must be such that it allows the physician to implant the monitoring system
in the shortest time possible.
3.1.1. Electromagnetic radiation
At frequencies between 10 MHz and 30 GHz, organic tissue warming is the major effect in
electromagnetic energy absorption and temperature increases of more than 1 or 2°C can have
adverse health effects [13].
A great number of physiological effects have been observed in cellular studies and with
animals when electromagnetic energy is absorbed in levels that cause an increment in body
temperature of more than 1 or 2°C [14]. These effects include alterations in neural and
neuromuscular functions, increased permeability of the blood‐brain barrier, ocular damage,
changes in the immune system associated with stress, haematological changes, reproductive
changes and changes in cell morphology.
Experimental data available indicate that human exposition in a resting position to electro‐
magnetic fields for 30 min, which produce a specific absorption rate (SAR) in the whole body
of 1–4 W kg−1, will result in an increase of temperature of less than 1°C. Exposition to electro‐
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magnetic fields more intense producing SAR values of more than 4 W kg‐1 may overwhelm
the thermoregulatory capacity of the body and produce warming tissue harmful levels. Table 1
shows basic restrictions for exposure to time‐varying electric and magnetic fields for frequen‐
cies up to 10 GHz.
Nature of the
exposition
Frequency range  Current density 
for head and
trunk (mA·m−2)
(rms)
SAR average for 
the whole body
(W·kg−1)
Localized SAR (head
and trunk) (W·kg−1)
Localized
SAR (limbs)
(W·kg−1)
Occupational
exposure
Up to 1 Hz
1–4 Hz
4 Hz to 1 kHz
1–100 kHz
100 kH to ‐10 MHz
10 MHz to 10 GHz
40
40/f
10
f/100
f/100
‐‐‐
‐‐‐
‐‐‐
‐‐‐
‐‐‐
0.4
0.4
‐‐‐
‐‐‐
‐‐‐
‐‐‐
10
10
‐‐‐
‐‐‐
‐‐‐
‐‐‐
20
20
General public
exposure
Up to 1 Hz
1–4 Hz
4 Hz to 1 kHz
1–100 kHz
100 kH to ‐10 MHz
10 MHz to 10 GHz
8
8/f
2
f/500
f/500
‐‐‐
‐‐‐
‐‐‐
‐‐‐
‐‐‐
0.08
0.08
‐‐‐
‐‐‐
‐‐‐
‐‐‐
2
2
‐‐‐
‐‐‐
‐‐‐
‐‐‐
4
4
Table 1. Basic restrictions for time‐varying electric and magnetic fields exposition for frequencies up to 10 GHz.
3.2. Engineering considerations
Regarding technological restrictions for the localization of the implant, we can find the
following:
• The implant must have the maximum area possible.
• The implant should be placed as near as possible from the exterior of the body.
Both of the previous considerations are based on the fact that the implant needs to maximize
power transfer and magnetic coupling.
IOP measurement requires the size of the implant not to be so large neither so bulky so it can
be implanted into the eye of the patient without causing any discomfort. This is the reason
why several IOP monitoring systems are based on radiofrequency identification (RFID)
technology [15].
Given that power consumption is a key factor in IOP monitoring system design, we may
classify electronic implants based on their power consumption briefly as described below.
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3.2.1. Active electronic implant
An active electronic implant will have active electronic components such as diodes and
transistors. By using active electronic components, there is the drawback of higher power
consumption. On the other hand, by using transistors and diodes the electronic implant would
have the advantage of having more precise and reliable pressure measurements.
3.2.2. Passive electronic implant
The passive option consists of having pure passive electronic components (resistors, capacitors
and inductors). The main advantage of this proposal is that power demand would be much
lower than its active counterpart so a possible health risk in the patient due to tissue warming
is greatly reduced.
Both types of implants will be discussed in more detail in Section 5.
4. Health issues due to tissue warming
A vital requirement when designing electronic implants is to limit temperature increment of
the implant in order to prevent damaging organic tissue. In general, temperature variation in
a body can be described by a partial differential equation of heat conduction which expresses
the variation in the temperature of a body with respect of time, but in order for this equation
to be used in human tissue, Pennes incorporated a few extra terms into the partial differential
heat conduction equation to describe the warming effect of basal metabolism and the influence
of blood in temperature regulation of tissue [16]. Pennes bio‐heat equation can be written as
follows:
( ) ( )r ¶ = Ñ × Ñ + - -¶ b
TC K T A B T Tt (1)
where A is the heat production rate due to metabolic processes per volume unit, B is the
perfusion constant and Tb is the blood temperature (it is assumed as a constant at Tb = 37°C).
The bio‐heat equation may be applied to human tissue without any external sources of heat.
For our case of study, however, the temperature increase in human tissue is also caused by
power dissipation of the electronic implant and by electromagnetic radiation coming from the
external device that will be supplying wireless power to the implant.
4.1. Joule heating
When considering an electronic implant inside the human body, power dissipation by
electronic circuitry has to be considered. Assuming that heat dissipation per volume unit of
an implant is Pi, this can be incorporated in the bio‐heat equation as a source of heat and is
expressed as
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=i i iP V * I (2)
where Vi is the biasing voltage of the electronic circuitry and Ii is the total electric current
circulating through the implant.
4.2. Electromagnetic energy contribution
If a biological tissue is exposed to electromagnetic radiation, the electric field E and the
magnetic field H penetrate the tissue causing it to warm up due to electromagnetic deposit.
On the other hand, SAR is the specific absorption rate and it is defined as the differential with
respect of time, of the increment of dissipated energy by a material. The SAR is related with
the magnitude of the electric field �  so, once we know the electric field distribution in the
tissue, we can obtain the SAR from which we can obtain the generated heat per volume unit
per time unit to include the term to the bio‐heat equation.
In order to have a complete bio‐heat equation, we need to include Joule heating and electro‐
magnetic energy contribution. The complete bio‐heat equation can be expressed as
( ) ( )r r¶ = Ñ × Ñ + - - + +¶ b i
TC K T A B T T SAR Pt (3)
Eq. (3) needs to be solved for each particular case of study to know how many degrees of
temperature will the tissue increase caused by the implant. For the graphic shown in Figure 4,
Eq. (3) was solved using Matlab software. Figure 4 shows a graphic of how an electronic
implant heats the tissue of the sclera when exposed to an electromagnetic energy radiation
and joule heating. Details of the implant design and characteristics are shown in Table 2.
Figure 4. Warming graphic of the sclera. Exposition time: 60 s.
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Parameter Value
Number of turns 18
Metal thickness 0.035 mm
Inner radius 1 mm
Outer radius 10 mm
Width of metal tracks 0.25 mm
Distance between tracks 0.25 mm
Resistance 150 Ω
Inductance 7.84 µH
Quality factor (Q) 3.28
Table 2. Proposed electrical parameters for the simulated reader coil.
5. Implant fabrication with passive and active electronic circuits
As stated in Section 3, we can classify electronic implants based on the nature of their compo‐
nents. Next, we describe both options.
5.1. Passive RLC implant
For this kind of approach, an Resistive Inductive Capacitive (RLC) passive circuit is proposed
as an IOP sensor like the one shown in Figure 5. The capacitor would be a variable capacitor,
sensitive to variations in pressure.
Figure 5. Electric diagram of the circuit proposed as an IOP sensor.
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The resonance frequency of the RLC circuit shown in Figure 5 is given by Eq. (4) where we can
note that if the value of capacitance varies, the resonance frequency of the circuit will change
too.
1
2p= s s
f L C (4)
From electromagnetic theory, we know that if we place two inductors close enough and we
make a time‐varying electric current circulate through one of the coils, it will induce a voltage
in the other coil. This is the principle by which wireless energy transfer is done. Figure 6 shows
a Maxwell‐Wien circuit which could act as the external device in charge of both delivering
power to the implant and reading data from it.
Figure 6. Maxwell‐Wien bridge circuit coupled with the coil from the implant.
The implant is shown inside the dotted lines. If the RLC circuit in the implant formed by Rs, Ls
and Cs is placed near the inductor Lx, a magnetic coupling will be created. By being Lx and Ls
coupled, a change in the capacitance of Cs will change the value of the resonance frequency of
the RLC circuit of the sensor which will in turn modify the impedance of Lx coil.
Eq. (5) shows how the impedance of the external device coil will vary by being coupled with
the coil of the implant [17]
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2
0 0
2 1
11
p
é ùæ öê úç ÷ê úè ø= +ê úê úæ ö- +ç ÷ê úê úè øë û
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fZ j fL k
f fjf Q f
(5)
where f is the resonance frequency of the external device, k is the coupling factor between both
coils, Q is given by
02 /p= s sQ f L R (6)
And f0 is the resonance frequency of the implant described previously in Eq. (4).
The main disadvantage for this approach is the lack of precision and accuracy in the meas‐
urements. If we were to obtain precise and accurate measurements with a very small error,
then both coils would have to be at the exact same place each time a measurement is to be
taken. We could assume that the implant is always fixed so in order to make this kind of
approach to work properly, the system design must be done to ensure that the coils will remain
in the same position for each measurement and no misalignment will occur.
Another important issue to be noted is the transmission medium between coils. So far, we have
considered air as the transmission medium between coils. Much more realistic calculations
and simulations may be performed if organic tissue is considered as the transmission medium
[18].
5.2. Electronic implant using transistors
Designing an electronic implant using transistors needs special care since they require a much
larger amount of power compared to passive RLC implants. Electronic circuit design must be
done in such a way that warming of the tissue does not exceed 1°C to avoid organic tissue
damage. Tissue warming is the main disadvantage of designing electronic implants using
transistors. On the other hand, they are very precise and accurate since measurements depend
only on having enough power available in the implant rather than if the coils are misaligned
or not.
The active electronic circuit for the implant can be divided into three sub‐modules, which are
reviewed below.
5.2.1. Rectifier and regulator circuit
As mentioned in Section 5.1, a time‐varying electric current circulating through one coil will
induce a time‐varying voltage in the other coil. Biasing in electronic circuits, however, requires
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a direct current (DC) voltage so that is when the rectifier and the regulator circuits come into
play.
5.2.1.1. Rectifier circuit
A rectifier circuit changes an alternating current into a direct current. It has a small error
though, since at the output the voltage has a little ripple. Figure 7 shows a full‐wave rectifier
with P‐type metal‐oxide semiconductor (PMOS) transistors.
Figure 7. PMOS rectifier circuit.
5.2.1.2. Regulator circuit
To get rid of the small ripple at the output of the rectifier, a regulator circuit is often added.
The aim of the regulator is to deliver a stable power supply voltage for proper operation of the
rest of the circuits in the implant. It has a minimum voltage needed at the input below which
it will not deliver a constant voltage. If the input voltage is, on the other hand, greater than the
minimum, then the regulator will output a constant voltage. This is the circuit responsible for
making active electronic implants independent of coils distance. If the distance between coils
is enough for the regulator to provide an output, it will provide a steady voltage regardless of
how close the coils are. If on the contrary, the distance between coils is not close enough, then
the voltage regulator simply will not provide any voltage at all. Figure 8 depicts a Comple‐
mentary Metal‐Oxide Semiconductor (CMOS) topology for a voltage regulator circuit.
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Figure 8. Topology of a voltage regulator. Taken with permission from [19].
5.2.2. Signal‐conditioning circuit
Once we have a stable DC voltage, we can move on to the next sub‐module of the implant. If
the sensor is in charge of transforming an analogue physical signal into an electric variable,
the signal‐conditioning circuit has the task of taking the analogue electric signal and manip‐
ulate it in such a way that it meets the requirements for the next stage in the system. For our
case, the next stage would be the transmission circuit.
Figure 9. Cross‐coupled LC VCO topology.
There are many electric circuit designs that can be used as a signal‐conditioning circuit. Here,
we take a brief look at a voltage‐controlled oscillator (VCO) [20]. As seen in Section 2, most
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pressure sensors are variable capacitors which change their value of capacitance according to
a change in pressure. On the other hand, a VCO is an oscillator with an oscillating frequency
that depends on the value of its capacitor. If we connect the pressure sensor with the VCO,
then we would have a signal‐conditioning circuit for IOP monitoring. In Figure 9, a cross‐
coupled LC VCO topology is shown.
5.2.3. Transmission circuit
The transmission circuit sub‐module takes the conditioned signal and transmits it back to the
external device. A power amplifier (PA) circuit can achieve the latter. Since we are discussing
circuits for an electronic implant, it would be desirable to have a low‐power amplifier to deal
with the transmission. There are many PAs from where we can choose; there are linear
amplifiers (Classes A, B and AB) or switched‐mode amplifiers (Classes E and F). In Figure 10,
a class E PA is shown. Switched‐mode amplifiers have a higher efficiency than linear ones (50–
70% in the case of linear vs. a theoretical 100% in switched‐mode amplifiers). Chapter 5 in [21]
has a deeper explanation in power amplifiers for biomedical implants.
Figure 10. Class E power amplifier. Taken with permission from [22].
6. Sensor and circuit integration
At this point, the reader may ask: Why do we even need this section since at present, sensors
and electronic circuits can be fabricated on the same substrate? And the answer is: Because it
depends on what type of application we want to develop.
It is true that nowadays it is possible to fabricate sensors and circuits in the same substrate.
The inconvenience with actual fabrication processes is that they use a rigid silicon wafer as a
substrate. For many applications, this is enough, but for biomedical applications this approach
is not useful. That is why in Section 2 all proposals that have active circuits in their designs
(such as the one shown in Figure 3) tend to divide the fabrication process of the implant. On
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one hand, they fabricate the coil in a flexible substrate such as parylene, silicone rubber or
polyimide so the implant can adapt to the curved surface of the eye. On the other hand, all
electronic circuitry and in general all IOP sensors too are fabricated in a rigid silicon wafer.
The final step involves connecting the coil with the sensor and the electronic circuits.
The main drawback from this approach is the potential damage that the silicon wafer can cause
to the tissue of the eye. Fortunately, there has been a significant advance in terms of electronic
circuit fabrication on a flexible substrate. In Figure 11, an electronic circuit fabrication process
with Carbon Nanotubes (CNT) on a flexible substrate and photographs of the final chip are
shown.
Figure 11. Circuit fabrication process on a flexible substrate. (a) Fabrication process of flexible InGaZnO‐CNT CMOS
logic circuits. Photographs of flexible CMOS circuits under (b) bending by hand and (c) rolling over a glass bar (∼2.6‐
mm radius). (d) Atomic Force Microscopy (AFM) image of CNT network film for p‐type type thin‐film Transistors
(TFT). (e) FEM simulation plot modelling the strain distribution in the InGaZnO channel region under bending (r = 2.6
mm). Taken with permission from [23].
7. Summary
In this chapter, we presented an overview of how an electronic implant can be designed. We
showed what has been done in this area over the years and we pointed to a major medical
concern that is tissue warming when it comes to implanting the IOP sensor into a patient.
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From an engineering perspective and despite the tremendous advance that has been made in
this area, there are still key issues that must be tackled in the years to come such as power
efficiency in wireless power transfer. Another aspect, not less important, is the possibility to
have electronic circuits fabricated in the same flexible substrate along with the pressure sensor.
This is an area of recent creation that has though an immense growth potential. Microelectronic
devices fabricated in a flexible substrate can have applications not only in intraocular pressure
monitoring but in many other biomedical applications. And these circuits can not only have
biomedical applications demand but also in other numerous engineering fields such as energy
harvesting, domotics and wearable technology (clothing and accessories).
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